BPA Call HT001419A0039-HT001420F0244
- Not listed
- This is a Blanket Purchase Agreement (BPA) call awarded by the Bureau of Medicine and Surgery, part of the Department of Defense's Defense Health Agency, to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The contract has a ceiling value of $250,000.00 and is for the delivery of various pharmaceutical products to support the operations of military healthcare facilities, particularly the Walter Reed National Military Medical Center in Bethesda, Maryland. The contract...
- This is a BPA call order awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is for the provision of pharmaceuticals, including shortage medications, to the Walter Reed National Military Medical Center in Bethesda, Maryland. The award, which has a ceiling value of $300,000.00, was made on July 2, 2015 and has a completion date of September 30,...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The $500,000.00 contract is for the provision of various pharmaceutical shortage items, including blood products, oncology pharmaceuticals, and other injectable, oral, and inhalation medications. The contract has no set-aside designation and was awarded on August 28, 2017 with a completion date of September...
- This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is for the supply of various pharmaceutical shortage items, blood products, and oncological pharmaceutical products. The award has a ceiling value of $100,000.00 and an ultimate completion date of May 26, 2017. The contract was awarded on May 19, 2017 and does not have a set-aside designation,...
- This is a $300,000.00 firm fixed-price Blanket Purchase Agreement (BPA) Call contract awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is for the supply of shortage pharmaceuticals and does not utilize any set-aside designation. Broughton Pharmaceuticals has a history of providing critical medical supplies and specialized pharmaceutical products to various federal healthcare agencies,...
- This federal contract award, valued at $75,000.00, was issued by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is a Blanket Purchase Agreement (BPA) call for the delivery of various pharmaceuticals, such as Amidate vials, Adrenaline 30ML MDV, and Atropine SYR, to support military healthcare operations. The contract has a firm fixed-price pricing type and an ultimate completion date of June 14,...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Navy, to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract, valued at $300,000.00, is for the supply of pharmaceutical products, including shortage items, to support the Naval Medical Center in Bethesda, Maryland. The contract is a firm fixed-price arrangement with no set-aside designation, indicating...
- This is a $150,000 Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Curium US LLC, a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract provides firm fixed price deliveries of various radiopharmaceutical products and services to support healthcare operations at military medical facilities, including Walter Reed National Military Medical Center. The contract has a period of performance through September 30, 2025 and no set-aside...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a defense agency, to TDS Med, Inc., a self-certified small disadvantaged business. The $400,000 contract is for the provision of shortage pharmaceuticals, including blood products, medical inhalations, injectables, and other relevant pharmaceutical products. The contract has a period of performance through September 30, 2016. This award is associated with a larger $2 million...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceutical supplies and drugs for the Walter Reed National Military Medical Center (WRNMMC). The $300,000 contract has an ultimate completion date of September 30, 2015 and was awarded on June 30, 2015. TDS Med, Inc. is an active federal contractor that has previously supported COVID-19 response...
- HT001419A0039Blanket Purchase Agreement
- HT001419A0039-HT001420F0244BPA Call
Broughton Pharmaceuticals, LLC was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency (DHA) to provide shortage pharmaceuticals such as Carimune and oncological pharmaceuticals for Walter Reed National Military Medical Center in Bethesda, Maryland. Valued at one hundred fifty thousand U.S. dollars ($150,000), the contract has a period of performance through August 2021 and was awarded in August 2020 without a set-aside designation. As the DHA oversees the Military Health System for all branches of the U.S. Armed Forces, this contract will help ensure service members and their families have reliable access to critical medications through one of the nation's leading military medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $150.0k | 8/21/20 |